 Mersana Therapeutics, Inc. NASDAQ:MRSN Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations and Corporate Communications Anna Protopapas - President, CEO Director Arvin Yang - Senior VP Chief Medical Officer Brian DeSchuytner - Senior VP CFO Conference Call Participants Jonathan Chang - SVB Securities Colleen Kusy - Baird Operator Good afternoon, and welcome to Mersana Therapeutics Second Quarter 2022 Conference Call and webcast. Currently, all participants are in a listen-only mode. 